Sintx Technologies (SINT) Net Cash Flow Growth (1y) (2014 - 2026)
Sintx Technologies (SINT) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 76.43% |
| 10 | Sintx Technologies | 6.02 Mn | 4.13 Mn | 144,000.00 | -177.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -177.57% |
| Dec 31, 2025 | -73.52% |
| Sep 30, 2025 | 650.97% |
| Jun 30, 2025 | -80.91% |
| Mar 31, 2025 | 19.82% |
| Dec 31, 2024 | 57.35% |
| Sep 30, 2024 | 108.31% |
| Jun 30, 2024 | 63.46% |
| Mar 31, 2024 | -61.87% |
| Dec 31, 2023 | -296.76% |
| Sep 30, 2023 | -3.51% |
| Jun 30, 2023 | -26.51% |
| Mar 31, 2023 | 286.28% |
| Dec 31, 2022 | 149.00% |
| Sep 30, 2022 | 40.05% |
| Jun 30, 2022 | -107.40% |
| Mar 31, 2022 | -81.38% |
| Dec 31, 2021 | -74.04% |
| Sep 30, 2021 | -156.08% |
| Jun 30, 2021 | -112.65% |